HeyTea Heats Up Premium Tea Market with Contrarian Price Cuts

Company lowers prices on some drinks, including a ‘Pure Green Tea’ drink costing less than 10 yuan Key takeaways: Leading new-style premium tea maker HeyTea has launched a recent round of price cuts, even as many rivals struggle with rising costs, stiff competition and Covid disruptions Chinese high-end tea makers raised $2.2 billion from investors last year, with nearly half going to HeyTea, whose latest valuation stood at nearly $10 billion By Jose Qian New-style tea drink makers have bubbled up all over China these last few years, thriving on…

Read More »

FAST NEWS: Shanghai Junshi Biosciences Expects its 2021 Loss to Narrow

The latest: Shanghai Junshi Biosciences Co., Ltd. (1877.HK, 688180.SH) announced its 2021 results forecast late Friday, estimating its net loss would be 736 million yuan ($115.7 million), narrowing from 933 million yuan a year earlier. Looking up: The company achieved operating revenue of 4.01 billion yuan last year, a 150% increase year-on-year, due to a significant growth in sales revenue from the commercialization of its core product, Toripalimab Injection, in the domestic market. Take Note: The company was still unable to turn around last year, due to increased investment in…

Read More »

Ganfeng Lithium Profit Soars on Skyrocketing Prices, as Company Moves Into Batteries

The lithium producer is moving aggressively to integrate its supply chain, as exploding demand for new energy batteries fuels its profits Key takeaways: Ganfeng Lithium said its profit last year surged as much as 4.37 times on soaring lithium prices Company’s new battery-related projects and new production capacity could provide important future growth engines By Fai Pui Sometimes known as “white oil”, lithium is probably the most talked-about periodic table element in financial markets lately. You are also probably no stranger to it, either. Given how important it is for…

Read More »

Missfresh Tries to Tempt Investors with Value-Added Offerings

Recent announcements show online grocer is adding higher-margin products and services to its lineup like ready-to-cook meals and prepackaged seasoning blends Key takeaways: •      Missfresh has launched a series of value-added initiatives in its bid to achieve profitability by selling more higher-margin products outside its core online grocery business •      Company’s stock is down more than 70% since its debut in the U.S. last June By Trevor Mo We may be losing money, but we’re working hard to find a recipe for success. That’s a key message in the latest…

Read More »

Jiangsu Recbio Shoots to Become Hong Kong’s First HPV Vaccine Stock

The vaccine producer is making a second attempt to list in Hong Kong, as its core HPV vaccine undergoes Phase 3 clinical trials Key takeaways: Jiangsu Recbio has filed a second IPO application to list in Hong Kong, hoping to become the first HPV vaccine maker in the market The company was valued at around 9 billion yuan after its latest funding round By Molly Wen What started as a chance to participate in trials for an HPV 9-valent vaccine, which protects again cervical cancer, turned into something more like…

Read More »

Daqo Taps Richly-Valued China-Listed Unit to Raise $1.7 Billion for Expansion

Polysilicon maker says the expansion that will double its capacity will begin construction in March and be complete in the third quarter of 2023 Key takeaways: Daqo New Energy will tap its China-listed subsidiary to raise funds for construction of a major new production facility in Inner Mongolia Daqo’s holdings in the China-listed unit, Xinjiang Daqo, are worth more than four times its own latest market value By Doug Young Now we finally know what China’s U.S.-listed solar companies are planning to do with their newly-listed Shanghai subsidiaries: use them…

Read More »

FAST NEWS: JPMorgan Discloses Major Stake in New Horizon Health

The latest: JPMorgan disclosed it purchased 701,600 shares in medical products maker New Horizon Health Ltd. (6606.HK) on Jan. 19, raising its stake above the 5% threshold that requires it to disclose its holdings. However, the bank reduced its stake by 427,500 shares the next day, bringing its shareholding back below the 5% reporting threshold. Looking up: JPMorgan’s purchase marks a strong vote of confidence in New Horizon,  which issued a positive profit forecast in mid-January saying its revenue last year doubled. Smaller stock buyers will often take their cues…

Read More »

Huazhu Ends 2021 with Omicron Hit, Seen Lingering Into 2022

The hotel operator is facing headwinds from the latest Covid-19 flare-up, whose impact is likely to affect its first quarter results Key takeaways: Huazhu Group is predicting greater uncertainties for its hotels in the first quarter as a result of the recent Covid resurgence and resulting travel restrictions The company has pivoted to focus on quality over quantity growth, in an unexpected shift for some analysts By Lau Ming With recent Covid-19 fare-ups sweeping China and the new omicron variant spreading fast, local governments throughout the country have been tightening…

Read More »

Full Truck Alliance Travels Bumpy Road Through Pandemic, Regulatory Wave

Trucking app operator’s fourth-quarter update showed strong but slowing growth, as it remains barred from signing up new customers pending outcome of a cybersecurity review Key takeaways: Full Truck Alliance said its fourth quarter fulfilled orders rose 41.6%, slowing from 78.4% growth in the previous quarter Growth comes as other major companies report business contractions in China due to Covid-control disruptions By Doug Young There are quite a few ways to look at the latest fourth-quarter update from Full Truck Alliance Co. Ltd. (YMM.US), reflecting just how complex China’s corporate…

Read More »

FAST NEWS: MicroPort Scientific’s Shanghai Unit Posted Up to 50% Profit Growth Last Year

The latest: Medical device maker MicroPort Scientific Corp. (0853.HK) said late on Monday that its 46%-owned subsidiary, Shanghai MicroPort Endovascular MedTech (Group) Co. Ltd. (688016.CN), will record a 40% to 50% profit increase for 2021. Looking up: Shanghai MicroPort’s revenue from its overseas business grew rapidly as the company increased its efforts in the international market. Take Note: MicroPort Scientific said recurrences of Covid-19 have affected heart-related surgeries, which could affect Shanghai MicroPort’s future sales, in turn affecting its own revenue and earnings performance. Digging Deeper: Shanghai MicroPort makes arterial…

Read More »